Eli Lilly and Company raised earnings guidance for the year 2024. For the year, the company expects revenue of $42.4 billion to $43.6 billion against previous guidance of $40.4 billion to $41.6 billion. Earnings per Share (reported) of $13.05 to $13.55 against previous guidance of $11.80 to $12.30.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
806.5 USD | +2.98% | +4.98% | +37.58% |
03:30pm | Central bankers try to reason with investors | |
03:22pm | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.58% | 705B | |
+32.59% | 583B | |
-3.22% | 364B | |
+19.98% | 332B | |
+5.31% | 291B | |
+16.91% | 238B | |
-3.56% | 210B | |
+10.40% | 209B | |
+9.20% | 169B | |
-1.30% | 162B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly and Company Raises Earnings Guidance for the Year 2024